PRESS RELEASE published on 07/10/2023 at 07:00, 2 years 9 months ago Biophytis has filed with the FDA for authorization to initiate SARA-31 phase 3 study in sarcopenia
PRESS RELEASE published on 06/19/2023 at 07:00, 2 years 10 months ago Biophytis reports clinical results for Sarconeos (BIO101) in sarcopenia treatment at the 16th SCWD International Congress
PRESS RELEASE published on 06/16/2023 at 23:00, 2 years 10 months ago Biophytis: RESULTS OF THE ANNUAL GENERAL MEETING ON JUNE 16, 2023 ALL RESOLUTIONS PRESENTED BY THE COMPANY HAVE BEEN ADOPTED
PRESS RELEASE published on 06/05/2023 at 08:00, 2 years 11 months ago Biophytis to participate at the BIO International Convention in Boston from the 5th to the 8th of June
PRESS RELEASE published on 05/26/2023 at 08:00, 2 years 11 months ago Biophytis has filed with the French National Authority for Health (HAS) an application for Early Access Authorisation (EAA) for Sarconeos (BIO101) in the treatment of severe forms of COVID-1
PRESS RELEASE published on 05/25/2023 at 08:00, 2 years 11 months ago Biophytis Presented Positive Results of Phase 2-3 COVA Study At The American Thoracic Society International Conference
PRESS RELEASE published on 05/15/2023 at 08:00, 2 years 11 months ago Biophytis has filed with the EMA for authorization to initiate SARA-31 phase 3 study in sarcopenia
PRESS RELEASE published on 05/11/2023 at 08:00, 2 years 11 months ago Successful capital increase for Biophytis with €2.3 million raised
PRESS RELEASE published on 05/10/2023 at 19:05, 2 years 11 months ago Biophytis launches a round of fundraising for approximately 2 million euros
PRESS RELEASE published on 05/09/2023 at 08:00, 2 years 11 months ago Biophytis has requested a pre-submission meeting with the EMA for the Marketing Authorisation of Sarconeos (BIO101) for the treatment of COVID-19
Published on 05/07/2026 at 02:00, 16 minutes ago Lobe Sciences Ltd. Announces Participation in the D. Boral Capital Global Conference in New York
Published on 05/06/2026 at 23:30, 2 hours 46 minutes ago Stabilis Solutions Announces First Quarter 2026 Results
Published on 05/06/2026 at 23:05, 3 hours 11 minutes ago Zomedica Announces Record First Quarter Revenue of $8.8 Million, Reflecting 35% Annual Growth; and $47.5 Million in Liquidity
Published on 05/06/2026 at 23:00, 3 hours 16 minutes ago Green Bridge Metals Strengthens Technical and Strategic Team as 2026 Work Programs Advance
Published on 05/06/2026 at 22:10, 4 hours 6 minutes ago Banyan Gold Announces Closing of $46.5 Million Private Placement
Published on 05/07/2026 at 00:47, 1 hour 29 minutes ago Blue Cap AG expands portfolio through the acquisition of Janoschka AG
Published on 05/07/2026 at 00:43, 1 hour 33 minutes ago EQS-Adhoc: Blue Cap AG Acquires Janoschka AG and Adjusts Forecast Due to Transaction
Published on 05/06/2026 at 20:32, 5 hours 44 minutes ago EQS-Adhoc: Kontron AG: ADHOC Kontron AG / Potential Public Takeover Bid by Ennoconn Corporation
Published on 05/06/2026 at 20:22, 5 hours 54 minutes ago EQS-Adhoc: ams-OSRAM AG: ams OSRAM delivers strong Q1 results, enters AI market through a development agreement with a leading AI photonics customer and sees path to positive Free Cash Flow in 2027
Published on 05/06/2026 at 19:18, 6 hours 58 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/06/2026 at 18:00, 8 hours 16 minutes ago Access to information in respect of the General Shareholders’ Meeting to be held on June 4, 2026
Published on 05/06/2026 at 18:00, 8 hours 16 minutes ago Information concerning the total number of voting rights and shares in the share capital as of April 30, 2026
Published on 05/06/2026 at 17:45, 8 hours 31 minutes ago Information concerning the total number of voting rights and shares 2026 04 30
Published on 05/06/2026 at 17:45, 8 hours 31 minutes ago Declaration of voting rights at the end of April 2026
Published on 05/06/2026 at 17:45, 8 hours 31 minutes ago Accor - Information regarding availability and consultation of preparatory documents - Shareholders' Meeting of May 27, 2026
